샘플 요청 목록

 카트 문의
시장보고서
상품코드
1768709

세계의 중재적 종양학 디바이스 시장

Interventional Oncology Devices
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 282 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 중재적 종양학 디바이스 시장은 2030년까지 39억 달러에 도달

2024년에 27억 달러로 추정되는 세계의 중재적 종양학 디바이스 시장은 2024-2030년의 분석 기간에 CAGR 6.4%로 성장하며, 2030년에는 39억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 색전 기기는 CAGR 7.3%를 기록하며, 분석 기간 종료시에는 24억 달러에 달할 것으로 예측됩니다. 절제 디바이스 분야의 성장률은 분석 기간의 CAGR로 5.3%로 추정됩니다.

미국 시장은 추정 7억 410만 달러, 중국은 CAGR 9.6%로 성장 예측

미국의 중재적 종양학 디바이스 시장은 2024년에 7억 410만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 분석 기간인 2024-2030년의 CAGR 9.6%를 견인하며, 2030년에는 예측 시장 규모 9억 1,560만 달러에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 3.4%와 5.7%로 예측됩니다. 유럽에서는 독일이 CAGR 3.9%로 성장할 것으로 예측됩니다.

세계의 중재적 종양학 디바이스 시장 - 주요 동향과 촉진요인 정리

중재적 종양학 기기는 어떻게 암 치료를 진행하고 있는가?

중재적 종양학 기기는 기존 수술의 필요성을 줄이고 주변 조직 손상을 최소화하면서 종양을 정확하게 표적화할 수 있는 최소침습적 수술을 제공함으로써 암 치료에 혁명을 일으키고 있습니다. 이 장비들은 방사선 소작요법(RFA), 마이크로파 소작요법(MWA), 경동맥화학색전술(TACE)과 같은 영상유도술에 사용되어 종양에 직접 표적치료를 시행합니다. 중재적 종양학 치료는 간암, 폐암, 신장암, 골암에 점점 더 많이 적용되고 있으며, 개복수술에 대한 대안으로 환자에게 보다 안전하고 덜 침습적인 치료법을 제공합니다. 이러한 기술은 생존율을 높이고, 회복 시간을 단축하며, 기존 수술이 적합하지 않은 환자들에게 새로운 희망을 가져다주고 있습니다.

중재적 종양학은 어떤 기술 혁신이 주도하고 있는가?

MRI, CT, 초음파 등 영상기술의 혁신은 치료 중인 종양을 실시간으로 고해상도로 볼 수 있게 하여 치료의 정확성과 안전성을 향상시키고, 치료 중 종양을 실시간으로 볼 수 있게 하여 치료의 정확성과 안전성을 향상시키고 있습니다. 향상시키고 있습니다. 로봇 시스템은 인터벤션의 정확도를 높이고, 손이 닿기 어려운 부위의 종양을 보다 정확하게 포착할 수 있게 해줍니다. 마이크로파 소작술과 냉동 소작술을 포함한 새로운 소작 기술은 정상 조직에 대한 손상을 최소화하면서 종양을 파괴하는 보다 효과적인 옵션을 제공합니다. 이러한 발전은 중재적 종양학의 역량을 확장하여 보다 광범위한 암을 치료할 수 있도록 돕고 있습니다.

시장 세분화는 중재적 종양학 장비의 성장을 어떻게 정의하는가?

장비 유형에는 절제 장비, 색전 기기, 색전 기기, 지지 장비가 있으며, 절제 장비는 저침습적 종양 파괴에 널리 사용되어 시장을 선도하고 있습니다. 시술에는 방사선 소작요법, 마이크로파 소작요법, 경동맥 화학색전술이 포함되며, 마이크로파 소작요법은 더 큰 종양의 치료에 높은 효과를 보여 인기를 끌고 있습니다. 중재적 종양학 장비로 치료되는 암 유형에는 간암, 폐암, 신장암, 골암 등이 있으며, 간세포암의 높은 유병률로 인해 간암이 가장 큰 부문을 형성하고 있습니다. 북미와 유럽 등의 지역에서는 높은 수준의 의료 인프라가 구축되어 있고 저침습적 치료의 도입이 활발히 이루어지고 있는 것이 시장 성장의 주요 요인으로 작용하고 있습니다.

중재적 종양학 기기 시장의 성장을 가속하는 요인은 무엇인가?

중재적 종양학 기기 시장의 성장은 암 발병률 증가, 최소침습적 치료에 대한 선호도 증가, 영상 및 절제 기술의 발전 등 여러 요인에 의해 주도되고 있습니다. 전 세계에서 암 발병률이 증가함에 따라 보다 최소침습적이고 표적화된 치료 옵션에 대한 수요가 증가하고 있습니다. 중재적 종양학은 환자에게 덜 외상적이고 회복이 빠른 시술을 제공함으로써 해결책을 제시할 수 있습니다. 실시간 영상 및 정밀 절제술의 혁신은 이러한 치료의 효과와 안전성을 향상시킴으로써 시장 성장을 더욱 촉진하고 있습니다. 또한 의료 인프라의 개선과 첨단 의료 기술에 대한 접근성 향상에 힘입어 신흥 시장에서 중재적 종양학의 채택이 증가하고 있는 것도 시장 확대에 기여하고 있습니다.

부문

디바이스(색전 디바이스, 절제 디바이스, 지원 디바이스), 암종(간암, 유방암, 폐암, 신장암, 전립선암, 기타 암종)

조사 대상 기업의 예

  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • BTG plc
  • C. R. Bard, Inc.
  • Cook Medical LLC
  • EDAP TMS S.A.
  • Healthtronics, Inc.
  • IMBiotechnologies Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Neuwave Medical, Inc.
  • Profound Medical Corp.
  • Sirtex Medical Limited
  • Teleflex Incorporated
  • Terumo Corporation
  • Trod Medical

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.07.17

Global Interventional Oncology Devices Market to Reach US$3.9 Billion by 2030

The global market for Interventional Oncology Devices estimated at US$2.7 Billion in the year 2024, is expected to reach US$3.9 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Embolization Devices, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$2.4 Billion by the end of the analysis period. Growth in the Ablation Devices segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$704.1 Million While China is Forecast to Grow at 9.6% CAGR

The Interventional Oncology Devices market in the U.S. is estimated at US$704.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$915.6 Million by the year 2030 trailing a CAGR of 9.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Interventional Oncology Devices Market - Key Trends and Drivers Summarized

How Are Interventional Oncology Devices Advancing Cancer Treatment?

Interventional oncology devices are revolutionizing cancer treatment by offering minimally invasive procedures that target tumors with precision, reducing the need for traditional surgery and minimizing damage to surrounding tissues. These devices are used in image-guided procedures such as radiofrequency ablation (RFA), microwave ablation (MWA), and transarterial chemoembolization (TACE), which deliver targeted therapies directly to tumors. Interventional oncology treatments are increasingly being adopted for liver, lung, kidney, and bone cancers, providing patients with safer, less invasive alternatives to open surgery. These technologies are improving survival rates, reducing recovery times, and offering new hope to patients who may not be candidates for traditional surgery.

What Technological Innovations Are Driving Interventional Oncology?

Technological advancements in imaging modalities, robotics, and ablation techniques are driving the growth of interventional oncology. Innovations in imaging technologies, such as MRI, CT, and ultrasound, are enabling real-time, high-resolution visualization of tumors during procedures, improving the accuracy and safety of treatments. Robotic systems are enhancing the precision of interventions, allowing for better targeting of tumors in hard-to-reach areas. New ablation techniques, including microwave ablation and cryoablation, are providing more effective options for tumor destruction while minimizing damage to healthy tissues. These advancements are expanding the capabilities of interventional oncology and allowing for the treatment of a broader range of cancers.

How Do Market Segments Define the Growth of Interventional Oncology Devices?

Device types include ablation devices, embolization devices, and support devices, with ablation devices leading the market due to their widespread use in minimally invasive tumor destruction. Procedures include radiofrequency ablation, microwave ablation, and transarterial chemoembolization, with microwave ablation gaining popularity due to its higher efficacy in treating larger tumors. Cancer types treated with interventional oncology devices include liver, lung, kidney, and bone cancers, with liver cancer being the largest segment due to the high prevalence of hepatocellular carcinoma. The market is growing significantly in regions such as North America and Europe, driven by the availability of advanced healthcare infrastructure and the increasing adoption of minimally invasive treatments.

What Factors Are Driving the Growth in the Interventional Oncology Devices Market?

The growth in the interventional oncology devices market is driven by several factors, including the increasing incidence of cancer, the growing preference for minimally invasive treatments, and advancements in imaging and ablation technologies. As cancer rates rise globally, demand for less invasive and more targeted treatment options is increasing. Interventional oncology offers a solution by providing procedures that are less traumatic for patients and offer faster recovery times. Technological innovations in real-time imaging and precision ablation are further driving market growth by improving the effectiveness and safety of these treatments. Additionally, the rising adoption of interventional oncology in emerging markets, driven by improving healthcare infrastructure and access to advanced medical technologies, is contributing to the expansion of the market.

SCOPE OF STUDY:

The report analyzes the Interventional Oncology Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device (Embolization Devices, Ablation Devices, Support Devices); Cancer Type (Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer, Other Cancer Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • BTG plc
  • C. R. Bard, Inc.
  • Cook Medical LLC
  • EDAP TMS S.A.
  • Healthtronics, Inc.
  • IMBiotechnologies Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Neuwave Medical, Inc.
  • Profound Medical Corp.
  • Sirtex Medical Limited
  • Teleflex Incorporated
  • Terumo Corporation
  • Trod Medical

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Interventional Oncology Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cancer Propels Growth in the Interventional Oncology Devices Market
    • Technological Advancements in Image-Guided Cancer Treatment Strengthen Demand for Interventional Devices
    • Growing Use of Minimally Invasive Procedures Fuels Adoption of Interventional Oncology Devices
    • Expansion of Radiofrequency Ablation and Cryoablation Techniques Drives Market Growth
    • Rising Focus on Targeted Cancer Therapies Expands Addressable Market for Interventional Devices
    • Technological Innovations in Microwave Ablation and Embolization Techniques Propel Market Growth
    • Increasing Adoption of Interventional Oncology in Liver, Lung, and Kidney Cancer Treatment Strengthens Market
    • Focus on Reducing Patient Recovery Time and Treatment Side Effects Fuels Demand for Minimally Invasive Solutions
    • Rising Demand for Image-Guided and Navigation-Assisted Cancer Therapies Expands Market Potential
    • Technological Advancements in Catheter-Based Delivery Systems Propel Growth in Interventional Oncology Devices
    • Increasing Focus on Palliative Care and Symptom Management in Cancer Patients Expands Market Opportunities
    • Rising Awareness of Early Cancer Detection and Treatment Options Strengthens Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Lung cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Lung cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Lung cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Liver Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Liver Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Liver Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Kidney Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Kidney Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Kidney Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Prostate Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Cancer Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Interventional Oncology Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Interventional Oncology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Interventional Oncology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Interventional Oncology Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Ablation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Ablation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Ablation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Support Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Support Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Support Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • JAPAN
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • CHINA
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • EUROPE
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Interventional Oncology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Interventional Oncology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Interventional Oncology Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • FRANCE
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • GERMANY
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Oncology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Interventional Oncology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Interventional Oncology Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • INDIA
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Interventional Oncology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Interventional Oncology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Interventional Oncology Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Argentina 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Brazil 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Mexico 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Interventional Oncology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Interventional Oncology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Interventional Oncology Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Iran 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Israel 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: UAE 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • AFRICA
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Africa 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제